Production, crystallization and X-ray diffraction analysis of two nanobodies against the Duffy binding-like (DBL) domain DBL6∊-FCR3 of the Plasmodium falciparum VAR2CSA protein. Corrigendum
aStructural Biology Brussels, Department of Biotechnology (DBIT), Vrije Universiteit Brussel, Pleinlaan 2, B-1050 Brussels, Belgium, bMolecular Recognition Unit (MoRe), Department of Structural Biology, VIB, Pleinlaan 2, B-1050 Brussels, Belgium, cInserm, UMRS665, F-75015 Paris, France, dUniversité Paris Diderot, F-75013 Paris, France, eInstitut National de la Transfusion Sanguine, F-75015 Paris, France, and fLaboratoire d'Excellence Gr-Ex, France
*Correspondence e-mail: email@example.com, firstname.lastname@example.org
A correction is made to Fig. 1 and the text of the article by Vuchelen et al. (2013, Acta Cryst. F69, 270–274) .
In the article by Vuchelen et al. (2013) there is a mistake in Fig. 1. The second line of Nb19 is a copy of the second line of Nb07, instead of the correct Nb19 line. This results in a difference of four amino acids. In §3, it is mentioned that there is one amino-acid substitution between the two nanobodies but this should be five (to include the four from the second line). Also the sequence identity should be 94% instead of 98%. A correct version of Fig. 1 is published here.
© International Union of Crystallography. Prior permission is not required to reproduce short quotations, tables and figures from this article, provided the original authors and source are cited. For more information, click here.